Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients

被引：0
|
作者：
Caihua Zhu
Bing Dai
Hua Zhan
Ruoyu Deng
机构：
[1] The Fourth People’s Hospital of Yueyang,Department of General Surgery
[2] Yueyang Traditional Chinese Medicine Hospital,Department of General Surgery
[3] Shanghai Jing’an District Central Hospital,Department of General Surgery
[4] Fudan University,School of Life Science
[5] University of Montpellier,Department of Health Management, Institute Montpellier Management
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷 / 3期
关键词：
Downstaging; Intermediate-stage hepatocellular carcinoma; Neoadjuvant therapy; Programmed cell death protein 1 inhibitor; Transarterial chemoembolization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1065 / 1071
页数：6
相关论文
共 50 条
  • [41] Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ferreira-Silva, Joel
    Costa-Moreira, Pedro
    Cardoso, Helder
    Liberal, Rodrigo
    Pereira, Pedro
    Macedo, Guilherme
    [J]. GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2023, 30 (01) : 29 - 37
  • [42] A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Ni, Jia-yan
    Fang, Zhu-ting
    Sun, Hong-liang
    An, Chao
    Huang, Zhi-mei
    Zhang, Tian-qi
    Jiang, Xiong-ying
    Chen, Yao-ting
    Xu, Lin-feng
    Huang, Jin-hua
    [J]. EUROPEAN RADIOLOGY, 2020, 30 (04) : 2377 - 2390
  • [43] Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. LIVER CANCER, 2024, 13 (01) : 29 - 40
  • [44] Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
    Hatanaka, Takeshi
    Yata, Yutaka
    Naganuma, Atsushi
    Kakizaki, Satoru
    [J]. CANCERS, 2023, 15 (06)
  • [45] RADIOLOGICAL PATTERN DETERMINES OUTCOMES OF TRANSARTERIAL CHEMOEMBOLIZATION (TACE) AND RISK OF TACE REFRACTORY IN INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA
    Hung, Ya-wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi Hsiang
    [J]. HEPATOLOGY, 2022, 76 : S1399 - S1400
  • [46] The safety and efficacy of transarterial chemoembolization (TACE) plus lenvatinib plus programmed cell death protein 1 (PD-1) antibody of advanced unresectable hepatocellular carcinoma
    Zhang, Xiaoyun
    Zhu, Xinrui
    Liu, Chang
    Lu, Wusheng
    Li, Qiu
    Chen, Weixia
    Li, Zhiping
    Lu, Qiang
    Peng, Wei
    Li, Chuan
    Yan, Lvnan
    Yang, Jiayin
    Wen, Tianfu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [47] Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review
    Ai, Haidong
    Gong, Ting
    Ma, Yongbiao
    Ma, Guixu
    Ding, Wei
    Ding, Weibao
    Wang, Wenjuan
    Zhao, Xuelin
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular carcinoma
    Sheng, Ye
    Wang, Qing
    Liu, Haifeng
    Wang, Qi
    Chen, Wenhua
    Xing, Wei
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1155): : 668 - 679
  • [49] Analysis of the Safety and Effectiveness of Lenvatinib plus TACE-HAIC + PD-1 Inhibitor for Intermediate and Advanced Hepatocellular Carcinoma
    Yang, Yuguang
    Tang, Hui
    Mai, Cong
    Zhang, Xin
    Kuang, Jiawen
    Tang, Yunqiang
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (11) : 2035 - 2045
  • [50] Type 2 diabetes mellitus worsens the prognosis of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization
    Liu, Guanghua
    Xia, Fang
    Fan, Guoping
    Yu, Juming
    Bao, Lei
    Zhang, Caiyuan
    Chi, Runmin
    Zhang, Tingting
    Wang, Lijun
    Shen, Feng
    Wang, Dengbin
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 169
12345